RxDoctor Payments Data

Adriance Edington

Physician Assistant · Monroe, NCNPI 1821728155

Payments from drug & device makers

$307in general payments, 2019–2025

Across 16 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$88
  • Boehringer Ingelheim$69
  • AbbVie$42
  • Novo Nordisk$38
  • Pfizer$21
  • GSK$19
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$307100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca5$88
Boehringer Ingelheim3$69
AbbVie2$42
Novo Nordisk2$38
Pfizer1$21
GSK1$19
Bayer1$15
Exact Sciences1$15

How this compares

$307 in reported general payments places this provider in the 50th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$16,652
Medicare patients
69
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol41$36,130
JardianceEmpagliflozin26$22,830
OzempicSemaglutide17$16,554
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,968
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl34$6,286
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$2,194
Albuterol Sulfate HfaAlbuterol Sulfate77$2,122
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,393
Amlodipine-ValsartanAmlodipine Besylate/Valsartan49$1,162
Atorvastatin Calcium153$1,086
Omeprazole58$790
Gabapentin63$779
Chlorthalidone56$690
ValacyclovirValacyclovir Hcl14$602
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13$499

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$88$36,13041 claims
Boehringer IngelheimJardiance$69$22,83026 claims
Novo NordiskOzempic$38$16,55417 claims
GSKTrelegy Ellipta$19$11,96817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Monroe

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →